Clinical Trials Directory

Trials / Completed

CompletedNCT01114659

The Study of Polycystic Ovary Syndrome(PCOS) With Gene and Questionnaire

The Study of Metabolic and Cardiac Vascular Risk in Patients With Polycystic Ovary Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
169 (actual)
Sponsor
Taipei Medical University WanFang Hospital · Academic / Other
Sex
Female
Age
15 Years – 45 Years
Healthy volunteers
Accepted

Summary

Polycystic ovary syndrome (PCOS) is an extremely common disorder in women of reproductive age. Diagnosis of PCOS is principally based on clinical and physical findings. Diagnostic criteria and PCOS definitions used by clinicians and researchers are almost as heterogeneous as the syndrome. This first part of study is determine whether genetic polymorphisms influence hormonal and metabolic characteristics in Taiwanese patients with PCOS and controls. Furthermore, women with PCOS were reported with high risk of cardiovascular disease, the investigators planned to calculate the difference of carotid intima-media thickness (IMT) and B-type natriuretic peptide (BNP) between women with PCOS and normal control to determine the premature atherosclerosis of women with PCOS.

Conditions

Timeline

Start date
2009-11-01
Primary completion
2010-08-01
Completion
2010-10-01
First posted
2010-05-03
Last updated
2014-01-01

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01114659. Inclusion in this directory is not an endorsement.